sprtherapeutics.comHealthcare / Medical DevicesFounded: 2010Funding to Date: $104.49MM
SPR Therapeutics is a medical device company specializing in the development and commercialization of non-opioid pain management solutions. SPR Therapeutics focuses on providing treatments designed for chronic and acute pain through its proprietary Peripheral Nerve Stimulation (PNS) technology. SPR Therapeutics was founded in 2010 and is headquartered in Cleveland, OH. SPR Therapeutics aims to improve the quality of life for individuals suffering from pain by delivering advanced, opioid-free treatment options that strive to reduce dependency and enhance patient outcomes.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
02/01/2024 | Series D-1 | $25.64MM | $xx.xx | $263.67MM | Mutual Capital Partners, Rc Capital, Revelation Partners | |
Price per Share
$xx.xx
Shares Outstanding
934,306
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
5.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Mutual Capital Partners, Rc Capital, Revelation Partners
|
||||||
10/18/2021 | Series D | $36.95MM | $xx.xx | $193.43MM | Mutual Capital Partners, Rc Capital, Revelation Partners | |
Price per Share
$xx.xx
Shares Outstanding
1,585,952
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
5.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Mutual Capital Partners, Rc Capital, Revelation Partners
|
||||||
01/18/2019 | Series C-1 | $8MM | $xx.xx | $85.91MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
555,043
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
5.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
09/12/2017 | Series C | $25MM | $xx.xx | $75.32MM | Frontcourt Ventures | |
Price per Share
$xx.xx
Shares Outstanding
1,788,614
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
5.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Frontcourt Ventures
|
||||||
06/30/2015 | Series B | $4.23MM | $xx.xx | $25.42MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
302,821
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
5.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
01/08/2013 | Series A | $4.66MM | $xx.xx | $15.54MM | Ndi Medical, Public Square Partners | |
Price per Share
$xx.xx
Shares Outstanding
333,597
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
5.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Ndi Medical, Public Square Partners
|